APLUS: Assuring Patient-centered Literacy Promotion for Underserved Children Study

Sponsor
Rutgers, The State University of New Jersey (Other)
Overall Status
Completed
CT.gov ID
NCT03242850
Collaborator
Robert Wood Johnson Foundation (Other)
160
1
2
19
8.4

Study Details

Study Description

Brief Summary

This study tests whether an enhanced primary cared based literacy promotion intervention consisting of a video and text message will increase shared reading occurrences between parents and children compared to the standard version.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention Group
N/A

Detailed Description

This is a randomized controlled trial aimed at assessing the effectiveness of an enhanced intervention consisting of a video and a series of text messages in promoting shared reading between parents and children. Participants will be randomized to one of two study arms (1) the enhanced intervention consisting of a video in the waiting room, standard guidance on shared reading, and a series of text messages (2) regular care which includes standard guidance on shared reading. The primary outcome will be shared reading occurrences. Secondary outcomes will include receipt of intervention, measure of the cognitive home environment, developmental screening results, and measure of parent reading beliefs.

Study Design

Study Type:
Interventional
Actual Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Assuring Patient-centered Literacy Promotion for Underserved Children to Promote School Readiness
Actual Study Start Date :
Jan 24, 2018
Actual Primary Completion Date :
Aug 24, 2019
Actual Study Completion Date :
Aug 24, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Regular care group

This group will receive regular care including standard guidance on shared reading. Participants in this arm will not view the video at the time of enrollment nor will they receive the text messages throughout the 6 months of the randomized controlled trial.

Experimental: Intervention group

Behavioral: Intervention Group
This group will view a video on shared reading upon enrollment, receive standard guidance on shared reading, and receive a series of text messages for a period of 6 months.

Outcome Measures

Primary Outcome Measures

  1. Reading Recall [Visit 2 (approx. 6 months)]

    Parents will report reading occurrences in a 1 week period including a 24-hour recall.

Secondary Outcome Measures

  1. Survey of Wellbeing of Young Children Milestones [Visit 2 (approx. 6 months)]

    Parents will complete the SWYC milestones, a validated, 10 item parent report, developmental screening tool.

  2. StimQ2 Read Scale / Parental Verbal Responsivity Scale [Visit 2 (approx. 6 months)]

    The StimQ2 is a parent reported measure of the cognitive home environment for children age 5 months to 6 years that assesses 4 domains: (1) Availability of Learning Materials (2) Reading (3) Parent Involvement in Developmental Advancement (4) Parental Verbal Responsiveness.

  3. Parental Reading Beliefs Inventory [Visit 2 (approx. 6 months)]

    Measure of parent reading beliefs

  4. Receipt of intervention [Visit 2 (approx. 6 months)]

    Parent report of receipt of guidance on shared reading

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. primary caregiver of a child age 6-15 months,

  2. primary language English or Spanish,

  3. cell phone ownership,

  4. age ≥18 years,

  5. willing to receive text messages, and

  6. willing to accept randomization

Exclusion Criteria:
  1. Individuals unable to provide consent

  2. Individuals who do not meet inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eric B. Chandler Health Center New Brunswick New Jersey United States 08901

Sponsors and Collaborators

  • Rutgers, The State University of New Jersey
  • Robert Wood Johnson Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manuel E. Jimenez, MD, MS, Assistant professor, Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT03242850
Other Study ID Numbers:
  • Pro20170000878
  • 73308
First Posted:
Aug 8, 2017
Last Update Posted:
Feb 18, 2020
Last Verified:
Feb 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Manuel E. Jimenez, MD, MS, Assistant professor, Rutgers, The State University of New Jersey

Study Results

No Results Posted as of Feb 18, 2020